FIRST AMENDMENT TO LICENSE AGREEMENT by and between ORGANON INTERNATIONAL GMBH and DARÉ BIOSCIENCE, INC.License Agreement • November 9th, 2023 • Dare Bioscience, Inc. • Pharmaceutical preparations
This First Amendment to License Agreement (this “First Amendment”) is entered into as of July 4, 2023 (the “Execution Date”) by and between Organon International GmbH, a limited liability company organized and existing under the laws of Switzerland (“Organon”) and Daré Bioscience, Inc., a corporation organized and existing under the laws of Delaware (“Daré”) (each a “Party” and collectively the “Parties”). Capitalized terms not defined herein are defined in the License Agreement.
